Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 2003
[Prostate-specific antigen and its related parameters in detecting prostate cancer]Hidetoshi Kuruma, Shin Egawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 25, 2012
[New biomarkers for the prostate cancer]Gen Ishii, Takahiro Kimura, Hidetoshi Kuruma, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 7, 2002
[Subsequent upper urothelial cancer following bladder tumor]Hidetoshi Kuruma, Teruaki Ao, Masakazu Murayama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 27, 2003
Delayed recovery of urinary continence after laparoscopic radical prostatectomyShin Egawa, Hidetoshi Kuruma, Kazuho Suyama, et al.
Current Cancer Drug Targets|March 23, 2013
Castration-resistant prostate cancer: novel therapeutics pre- or post- taxane administrationMasaki Shiota, Akira Yokomizo, Naohiro Fujimoto, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 30, 2005
Occupational bladder cancer: from cohort study to biologic molecular markerKazumasa Matsumoto, Akira Irie, Takefumi Satoh, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 3, 2006
Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate glandKazumasa Matsumoto, Shin Egawa, Takefumi Satoh, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 31, 2013
Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapyHiroshi Sasaki, Masahito Kido, Kenta Miki, et al.
BJU International|September 14, 2007
The maximum tumour length in biopsy cores as a predictor of outcome after radical prostatectomyNorihiro Hayashi, Mitsuyoshi Urashima, Hidetoshi Kuruma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesisFrancois Lamoureux, Christian Thomas, Min-Jean Yin, et al.
Pageof 4